Sichuan Hebang Biotechnology Corporation Limited (603077.SS)
CNY 1.71
(-1.16%)
CNY 1.71
(-1.16%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -763.82 Million CNY | 72.44% |
| 2022 | -2.77 Billion CNY | -719.77% |
| 2021 | -338.09 Million CNY | -126.02% |
| 2020 | 1.29 Billion CNY | 2.67% |
| 2019 | 1.26 Billion CNY | 808.21% |
| 2018 | -178.68 Million CNY | -310.66% |
| 2017 | 84.82 Million CNY | -90.88% |
| 2016 | 930.37 Million CNY | -69.03% |
| 2015 | 3 Billion CNY | -3.92% |
| 2014 | 3.12 Billion CNY | 90.54% |
| 2013 | 1.64 Billion CNY | 2822.44% |
| 2012 | 56.15 Million CNY | -96.32% |
| 2011 | 1.52 Billion CNY | -3.36% |
| 2010 | 1.57 Billion CNY | -3.69% |
| 2009 | 1.63 Billion CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 870.1 Million CNY | 213.91% |
| 2024 Q2 | 1.56 Billion CNY | 79.39% |
| 2024 Q3 | 2.13 Billion CNY | -81.04% |
| 2023 Q2 | -2.33 Billion CNY | 21.3% |
| 2023 FY | -763.82 Million CNY | 72.44% |
| 2023 Q4 | -763.82 Million CNY | 60.15% |
| 2023 Q3 | -1.91 Billion CNY | 17.73% |
| 2023 Q1 | -2.96 Billion CNY | -6.82% |
| 2022 Q3 | -2.05 Billion CNY | 3.83% |
| 2022 Q2 | -2.13 Billion CNY | -51.92% |
| 2022 Q1 | -1.4 Billion CNY | -315.23% |
| 2022 FY | -2.77 Billion CNY | -719.77% |
| 2022 Q4 | -2.77 Billion CNY | -35.13% |
| 2021 FY | -338.09 Million CNY | -126.02% |
| 2021 Q4 | -338.09 Million CNY | 39.74% |
| 2021 Q2 | 168.49 Million CNY | -85.98% |
| 2021 Q3 | -561.09 Million CNY | -433.0% |
| 2021 Q1 | 1.2 Billion CNY | -7.5% |
| 2020 Q3 | 1.58 Billion CNY | 20.46% |
| 2020 FY | 1.29 Billion CNY | 2.67% |
| 2020 Q1 | 1.43 Billion CNY | 13.48% |
| 2020 Q2 | 1.31 Billion CNY | -8.23% |
| 2020 Q4 | 1.29 Billion CNY | -18.15% |
| 2019 Q3 | 1.11 Billion CNY | 36.98% |
| 2019 Q2 | 815.74 Million CNY | 23.04% |
| 2019 Q1 | 662.99 Million CNY | 471.04% |
| 2019 FY | 1.26 Billion CNY | 808.21% |
| 2019 Q4 | 1.26 Billion CNY | 13.25% |
| 2018 FY | -178.68 Million CNY | -310.66% |
| 2018 Q4 | -178.68 Million CNY | -31.32% |
| 2018 Q3 | -136.07 Million CNY | -20.56% |
| 2018 Q2 | -112.86 Million CNY | -240.43% |
| 2018 Q1 | 80.37 Million CNY | -5.25% |
| 2017 Q4 | 84.82 Million CNY | -43.64% |
| 2017 FY | 84.82 Million CNY | -90.88% |
| 2017 Q3 | 150.49 Million CNY | -4.6% |
| 2017 Q2 | 157.74 Million CNY | -82.31% |
| 2017 Q1 | 891.95 Million CNY | -4.13% |
| 2016 Q3 | -565.2 Million CNY | -117.6% |
| 2016 Q4 | 930.37 Million CNY | 264.61% |
| 2016 Q1 | 2.98 Billion CNY | -0.49% |
| 2016 FY | 930.37 Million CNY | -69.03% |
| 2016 Q2 | 3.21 Billion CNY | 7.41% |
| 2015 FY | 3 Billion CNY | -3.92% |
| 2015 Q1 | 3.21 Billion CNY | 2.67% |
| 2015 Q4 | 3 Billion CNY | 19.04% |
| 2015 Q3 | 2.52 Billion CNY | 21.41% |
| 2015 Q2 | 2.07 Billion CNY | -35.25% |
| 2014 FY | 3.12 Billion CNY | 90.54% |
| 2014 Q3 | 3.09 Billion CNY | 5.68% |
| 2014 Q4 | 3.12 Billion CNY | 1.19% |
| 2014 Q2 | 2.92 Billion CNY | 79.74% |
| 2014 Q1 | 1.62 Billion CNY | -0.87% |
| 2013 Q1 | 387.89 Million CNY | 590.76% |
| 2013 Q2 | 1.25 Billion CNY | 222.38% |
| 2013 Q3 | 1.32 Billion CNY | 5.65% |
| 2013 Q4 | 1.64 Billion CNY | 24.22% |
| 2013 FY | 1.64 Billion CNY | 2822.44% |
| 2012 FY | 56.15 Million CNY | -96.32% |
| 2012 Q4 | 56.15 Million CNY | -52.21% |
| 2012 Q3 | 117.51 Million CNY | -92.98% |
| 2012 Q2 | 1.67 Billion CNY | 0.0% |
| 2011 FY | 1.52 Billion CNY | -3.36% |
| 2011 Q4 | 1.52 Billion CNY | 0.0% |
| 2010 FY | 1.57 Billion CNY | -3.69% |
| 2009 FY | 1.63 Billion CNY | 0.0% |